Skip Ribbon Commands
Skip to main content
Menu
Dr Charles Ng Jun Han

Dr Ng Jun Han Charles

MBBS (Singapore), GDFM (Family Medicine), MRCP (UK), MMed (Internal Medicine)

Consultant

Changi General Hospital

Specialty: Renal Medicine

Conditions Treated by this Doctor:
Hemodialysis.

Clinical Appointments

  • Consultant Renal Medicine Changi General HospitalChangi General Hospital

Academic Appointments

  • Clinical Faculty, SingHealth Renal Medicine Residency Programme

Profile

Dr Charles Ng is a Consultant with the Department of Renal Medicine at Changi General Hospital (CGH). He graduated with MBBS from the National University of Singapore (NUS) in 2012 and obtained his Membership of the Royal Colleges of Physicians (United Kingdom) in 2017. He subsequently completed specialist training in nephrology in 2022.

Dr Charles is a general nephrologist trained in various aspects of nephrology, with clinical interests in critical care nephrology and hemodialysis.

Education

  • MMed (Internal Medicine) 2018
  • MRCP (UK) 2017
  • GDFM (Graduate Diploma in Family Medicine) 2016
  • MBBS (Singapore) 2012

Professional Appointments and Committee Memberships

Awards

  • SingHealth Medicine ACP Pitch for Fund Award, 2020
  • SingHealth Associate in Education, 2020

Research Interests

  • Advances in Hemodialysis
  • Dialyzer Membranes

Publications

  • Regional Citrate Anti-Coagulation Dose Titration – Impact on Dose of Continuous Renal Replacement Therapy. Ng CJH, Poh CB, Koduri S, Roy DM, Siau C, Lim NL, Chionh CY. Clinical and Experimental Nephrology 2021 Sep;25(9):963-969
  • A 'Dagger' in the Abdomen – An Unusual Cause of Abdominal Pain. Ng CJH, Lim CC, Fong W, Foo M. Eur J Rheumatol 2021 Jul;8(3):182-183
  • Interpretation of hip fracture patterns using areal bone mineral density in the proximal femur. Hey HW, Sng WJ, Lim JL, Tan CS, Gan AT, Ng CJH, Kagda FH. Arch Orthop Trauma Surg. 2015 Dec;135(12):1647-53

Research Trials

  • Continuous Non-invasive Hemodynamic Monitoring and Profiling of Chronic Stable and Acutely Ill Patients undergoing Haemodialysis with ClearSight – A Pilot Study, Ongoing recruitment